Abstract
Introduction
It is not well established to use vitamin D supplementation for migraine, and this
meta-analysis aims to explore the efficacy of vitamin D for migraine patients.
Methods
PubMed, EMbase, Web of science, EBSCO and Cochrane library databases were systematically
searched up to May 2021, and we included randomized controlled trials (RCTs) exploring
the effect of vitamin D for migraine patients.
Results
Six RCTs and 301 patients were included in the meta-analysis. Compared with control
group in migraine patients, vitamin D supplementation could remarkably decrease headache
attacks per month (MD = −2.74; 95% CI = −3.82 to −1.67; P < 0.00001), headache days per month (MD = −1.56; 95% CI = −2.44 to −0.68; P = 0.0005) and MIDAS score (MD = −5.72; 95% CI = −10.90 to −0.54; P = 0.03), but demonstrated no obvious influence on attack duration (MD = −2.20; 95%
CI = −7.38 to 2.97; P = 0.40) or headache severity (MD = −0.56; 95% CI = −1.18 to 0.06; P = 0.08).
Conclusions
Vitamin D supplementation provided additional benefits to treat migraine.
Keywords
To read this article in full you will need to make a payment
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Migraine is first cause of disability in under 50s: will health politicians now take notice?.J. Headache Pain. 2018; 19: 17
- GBD 2015: migraine is the third cause of disability in under 50s.J. Headache Pain. 2016; 17: 104
- The global burden of headache: a documentation of headache prevalence and disability worldwide.Cephalalgia. 2007; 27: 193-210
- Sex differences in the epidemiology, clinical features, and pathophysiology of migraine.Lancet Neurol. 2017; 16: 76-87
- Complementary and alternative medicine use for headache and migraine: a critical review of the literature.Headache. 2013; 53: 459-473
- Systematic review of migraine prophylaxis adherence and persistence.J. Manag. Care Pharm.: JMCP. 2014; 20: 22-33
- Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II).Headache. 2013; 53: 644-655
- Vitamin D in migraine headache: a comprehensive review on literature.Neurol. Sci. 2019; 40: 2459-2477
- A randomized, double-blinded, placebo-controlled, parallel trial of vitamin D3 supplementation in adult patients with migraine.Curr. Med. Res. Opin. 2019; 35: 715-723
- Efficacy of vitamin D replacement therapy on patients with chronic nonspecific widespread musculoskeletal pain with vitamin D deficiency.Int. J. Rheum. Dis. 2016; 19: 1255-1262
- Effect of vitamin D supplementation on symptoms and C-reactive protein in migraine patients.J. Res. Med. Sci. 2015; 20: 477-482
- Effect of vitamin D on musculoskeletal pain and headache: a randomized, double-blind, placebo-controlled trial among adult ethnic minorities in Norway.Pain. 2014; 155: 2591-2598
- Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial.Neurol. Sci. 2020 May; 41: 1183-1192
- The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial.J. Headache Pain. 2020; 21: 22
- Efficacy of Topiramate alone and Topiramate plus vitamin D3 in the prophylaxis of pediatric migraine: a randomized clinical trial.Iran. J. Child Neurol. 2020; 14: 77-86
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.Bmj. 2009; 339: b2535
- Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. 0 [Updated March 2011].The Cochrane Collaboration, 2011
- Assessing the quality of reports of randomized clinical trials: is blinding necessary?.Control. Clin. Trials. 1996; 17: 1-12
- Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses.Ann. Intern. Med. 2001; 135: 982-989
- Quantifying heterogeneity in a meta-analysis.Stat. Med. 2002; 21: 1539-1558
- Effect of vitamin D supplementation on symptoms and C-reactive protein in migraine patients.J. Res. Med. Sci. 2015; 20: 477-482
- Simvastatin and vitamin D for migraine prevention: a randomized, controlled trial.Ann. Neurol. 2015; 78: 970-981
- Vitamin D in migraine headache: a comprehensive review on literature.Neurol. Sci. 2019; 40: 2459-2477
- Serum vitamin D status in a Group of Migraine Patients Compared with Healthy Controls: a case–control study.Headache. 2018; 58: 1530-1540
- A phase-by-phase review of migraine pathophysiology.Headache. 2018; 58: 4-16
- Understanding migraine: potential role of neurogenic inflammation.Ann. Indian Acad. Neurol. 2016; 19: 175-182
- CGRP and the trigeminal system in migraine.Headache. 2019; 59: 659-681
- The trigeminovascular pathway: role of CGRP and CGRP receptors in migraine.Headache. 2017; 57: 47-55
- Migraine, Neurogenic inflammation, drug development - pharmacochemical aspects.Curr. Med. Chem. 2017; 24: 3649-3665
- Neurogenic inflammation and its role in migraine.Semin. Immunopathol. 2018; 40: 301-314
- The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache.Pharmacol. Ther. 2008; 120: 157-171
- Risk assessment for vitamin D.Am. J. Clin. Nutr. 2007; 85: 6-18
Article Info
Publication History
Published online: October 13, 2021
Accepted:
July 31,
2021
Received in revised form:
July 30,
2021
Received:
June 2,
2020
Identification
Copyright
© 2021 Published by Elsevier Inc.
